Meta-analysis: Clinicopathological and prognostic significance of cyclooxygenase-2 expression on oesophageal squamous cell carinoma

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 6, 2009, Pages 589-596

  Li, L ^a   Zhao, J ^b   Wu, Z ^b   Wang, G ^b   Chen, G ^b  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE SEVERITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MEDLINE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS;

EID: 68949211159     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04069.x     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108.
2. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997 94 : 3336 40.
3. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998 93 : 705 16.
4. Dannenberg AJ, Altorki NK, Boyle JO, et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2001 2 : 544 51.
5. Gallo O, Masini E, Bianchi B, et al. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 2002 33 : 708 14.
6. Ranger GS, Thomas V, Jewell A, et al. Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer. Anticancer Res 2004 24 : 2349 51.
7. Ristimaki A, Honkanen N, Jankala H, et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997 57 : 1276 80.
8. Sheehan KM, Sheahan K, O'Donoghue DP, et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 1999 282 : 1254 7.
9. Yip-Schneider MT, Barnard DS, Billings SD, et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis 2000 21 : 139 46.
10. Shirahama T, Arima J, Akiba S, et al. Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer 2001 92 : 188 93.
11. Hida T, Yatabe Y, Achiwa H, et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinoma. Cancer Res 1998 58 : 3761 4.
12. Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006 55 : 115 22.
13. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998 17 : 2815 34.
14. Hashimoto N, Inayama M, Fujishima M, et al. Clinicopathocologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinoma. Hepatogastroenterology 2007 54 : 758 60.
15. Kuo KT, Chow KC, Wu YC, et al. Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma. Ann Thorac Surg 2003 76 : 909 14.
16. Liu JF, Jamieson G, Wu TC, et al. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Dis Esophagus 2006 19 : 350 4.
17. Takatori H, Natsugoe S, Okumura H, et al. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma. Eur J Surg Oncol 2008 34 : 397 402.
18. Kawabe A, Shimada Y, Uchida S, et al. Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology 2002 62 : 46 54.
19. Heeren P, Plukker J, van Dullenmen H, et al. Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma. Cancer Lett 2005 225 : 283 9.
20. Nozoe T, Ezaki T, Kabashima A, et al. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus. Am J Surg 2005 189 : 110 5.
21. Shamma A, Yamamoto H, Doki Y, et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 2000 6 : 1229 38.
22. Sivula A, Buskens CJ, van Rees BP, et al. Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus. Int J Cancer 2005 116 : 903 8.
23. Shunwen W, Qing G. Relationship between expression of cyclooxygenase-2 and clinicopathological characteristic and prognostic significance in human esophageal carcinoma. Chin J Cancer Prev Treat 2004 11 : 1051 3.
24. Zhong Yu, Yuhong Y, Jinxin Z, et al. Relationship between expression of COX-2 and clinicopathological features in esophageal carcinoma. Chin J Pathophys 2006 22 : 2212 7.
25. Okawa T, Naomoto Y, Nobuhisa T, et al. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin Cancer Res 2005 11 : 7995 8005.
26. Miyashita M, Makino H, Katsuta M, et al. Cyclo-oxygenase-2 over-expression is associated with human esophageal squamous cell carcinoma. J Nippon Med Sch 2006 73 : 308 13.
27. Yang GZ, Li L, Ding HY, et al. Cyclooxygenase-2 is over-expressed in Chinese esophageal squamous cell carcinoma, and correlated with NF-kappaB: an immunohistochemical study. Exp Mol Pathol 2005 79 : 214 8.
28. Kase S, Osaki M, Honjo S, et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma. Pathobiology 2004 71 : 84 92.
29. Sujuan F, Shuiping H, Lixin Z, et al. Expression of COX-2, p53 and PCNA in esophageal carcinoma and its significance. China Oncology 2003 13 : 17 20. (in Chinese)
30. Songmiao C, Xilong Ou, Werhao S, et al. Expression of cyclooxygenase-2 in esophageal carcinoma and its correlation with angiogenesis. World J Gastroenterol 2006 14 : 1388 93. (in Chinese)
31. Yufang C, Meizhen W, Yongjuan S. Expression of cyclooxygenase-2 in esophageal cancer and its correlation with P53. Modern Oncology 2007 15 : 360 3. (in Chinese)
32. Qiang Z, Yushu Mu, Zongxin W, et al. Correlation of cyclooxygenase-2 mRNA expression with occurrence and development of esophageal carcinoma. Chin J Cancer Prev Treat 2008 15 : 178 80. (in Chinese)
33. Huang WZ, Fu JH, Wang DK, et al. Overexpression of cyclooxygenase-2 is associated with chemotherapy resistance and prognosis in esophageal squamous cell carcinoma patients. Dis Esophagus 2008 21 : 679 84.
34. Yoshikawa R, Fujiwara Y, Koishi K, et al. Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence. World J Gastroenterol 2007 13 : 2283 8.
35. Kulke MH, Odze RD, Mueller JD, et al. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. J Thorac Cardiovasc Surg 2004 127 : 1579 86.
36. Khor L-Y, Bae K, Pollack A, et al. COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. Lacet Onco 2007 8 : 912 20.